|
|
|
|
|
|
|
| A Sudden Onset, a Fatal Complication |
|
Malignant hyperthermia claimed the life of a Florida teen after a routine cosmetic surgery late last month in a case that demonstrates how unpredictable, sudden and potentially fatal the rare complication is.
Stephanie Kuleba, 18, underwent corrective breast augmentation surgery on March 21 to reshape asymmetrical breasts and an inverted areola. The outpatient procedure was conducted at the office-based ASC of Steven Schuster, MD, a board-certified plastic surgeon based in Boca Raton.
About two hours into the procedure and without warning, Ms. Kuleba's heart rate and metabolism increased, her core temperature spiked to over 110 degrees F, her body became rigid and she was diagnosed with MH.
According to news reports, a staff member called the Malignant Hyperthermia Association of the United States' MH hotline. A Mayo Clinic expert guided Dr. Schuster, his anesthesia provider and the surgical team through emergency procedures. Ms. Kuleba was transported by ambulance to the Delray Medical Center three miles away, but she died the following day.
Surgical authorities quoted in news coverage of the incident attest to the genetic condition's rarity and severity.
In a similar surgical emergency, says Jeff Jacobs, MD, staff anesthesiologist at the Cleveland Clinic's Weston, Fla., campus, "there would be three to five things I'd do before I think of malignant hyperthermia. As you go through your checklist, you're soon left with some scary things. One of those is malignant hyperthermia."
David A. Lubarsky, MD, MBA, chair of the anesthesiology department at the University of Miami's medical school, describes the speed and precision necessary in responding to MH. "No matter how hard this surgeon worked, a full-blown, fulminant case of malignant hyperthermia would take more than one pair of experienced hands," he says.
David Bernard |
|
 |
^ Back to Top |
|
|
|
|
| N.J. Senate Adopts Changes to ASC Self-referral Law |
|
A proposed amendment to New Jersey's Healthcare Practitioner Self-referral Law, also known as the Codey Law, passed the state Senate on March 17. If the bill becomes law, physicians will be legally able to refer patients to surgical facilities in which they have financial interests. It would also set a two-year moratorium on new licenses for surgery centers.
The amendment, introduced by Senate President (and the Codey law's original sponsor) Richard Codey, would clear up the controversy over the self-referral law that originated last November from insurance litigation in which state Superior Court Judge Robert P. Contillo unexpectedly ruled that physician-owned ASCs violated the law.
The ruling caused concern among physicians and prompted the New Jersey Board of Medical Examiners to propose emergency amendments to its regulations in order to allow physician-owned ASCs to temporarily operate without fear of breaking the law.
"This bill recognizes that these physicians [operated] in good faith and in the open. In fact, they did so in broad daylight," said Richard J. Scott, MD, president of the Medical Society of New Jersey, to the Senate Health and Human Services Committee before the bill's adoption.
Kent Steinriede |
|
|
^ Back to Top |
|
|
|
|
| Colorectal Cancer Beginnings May Be Hard to Spot |
|
A study published in the March 5 issue of the Journal of the American Medical Association challenges the common belief that polyps are the primary cause of colon cancer.
Researchers from the Veterans Affairs Palo Alto Health Care System in California reviewed data from 1,819 patients who underwent elective colonoscopies over a one-year period. They found that 170 of the patients had nonpolypoid colorectal neoplasms, which were almost ten times more likely to contain carcinomas than polypoid lesions of any size.
Viewed in terms of size and shape, nonpolypoid neoplasms with carcinomas tended to be smaller in diameter by a mean difference of about three millimeters than polypids containing carcinomas. The researchers also reported that depressed nonpolyp neoplasms carried the highest risk of containing invasive carcinomas.
The study's authors suggest that stronger efforts to detect these neoplasms in addition to polyps could make colonoscopies more effective at preventing cancer. But they also noted that lesions that turn cancerous look the same regardless of their origins.
Nathan Hall |
|
|
^ Back to Top |
|
|
|
|
| News and Notes |
|
ORAL SODIUM PHOSPHATE DISRUPTS RENAL FUNCTION in elderly patients and should be discouraged from use in their cases, says nephrologist Anand Khurana, MD, of the Scott & White Clinic at Texas A&M University in Temple, Texas. After discovering 15 cases of acute phosphate nephropathy among elderly Caucasian women in one year, Dr. Khurana and colleagues studied the effects of the common bowel prep on colonoscopy patients' kidneys. According to their study, published in the March 24 issue of the Archives of Internal Medicine, patients who had taken oral sodium phosphate, which has a black box warning, saw a 6 percent drop in kidney function after six months as compared to patients who didn't receive the compound or a control group who didn't undergo colonoscopies. Dr. Khurana says Scott & White no longer uses oral sodium phosphate solutions for bowel prep, opting for polyethylene glycol solutions instead.
ETHICON ENDO-SURGERY IS SEEKING FDA APPROVAL for its Sedasys system, which it promotes as the first computer-assisted personalized sedation system intended for use by physician-and-nurse teams to administer minimal or moderate propofol sedation during colonoscopies without the presence of anesthesia providers. While current propofol labeling restricts its use to those trained in general anesthesia, a favorable FDA review of Ethicon's pre-market approval application, submitted last week, could change that. The Sedasys CAPS system delivers patient sedation while monitoring and recording parameters and is able to react to oversedation by stopping or reducing drug delivery.
PHYSICIANS CAN NOW RECEIVE FDA WARNINGS in their e-mail inboxes, thanks to the Health Care Notification Network - a system developed by an alliance of medical societies, insurance companies, pharmaceutical manufacturers and other healthcare groups. Licensed physicians who sign up for the free service will receive drug and medical device warnings via e-mail long before they receive the FDA's conventional postal mail notifications. The e-mailed alerts are intended to reach physicians directly, eliminating the possibility that conventional letters will be discarded as junk mail before reaching the physician's desk, says Janet Woodcock, MD, chief medical officer and acting director of the Center for Drug Evaluation and Research. The electronic warning system will not be used for marketing or advertising purposes, the network says.
A PATIENT'S SATISFACTION WITH TREATMENT OPTIONS FOR PROSTATE CANCER depends largely on associated changes in his quality of life, reports a study published in the March 20 issue of the New England Journal of Medicine. In the first multicenter study to analyze the satisfaction of patients and their partners with the overall outcome of prostate cancer treatment, researchers examined the impact of treatments on sexual and bowel function, urinary incontinence, urination problems due to prostate enlargement and male hormonal function. The researchers discovered that hormonal therapy worsened multiple aspects of a patient's quality of life and had significant negative effects on men's vitality and sexuality when combined with brachytherapy or with external radiation. Additionally, say the researchers, some men experienced urinary incontinence problems after having their prostates surgically removed while nerve-sparing techniques reduced sexual side effects but did not eliminate them. |
|
|
^ Back to Top |
|
|
|
|
|
